05.03.2013
- U.S. regulators granted Pfizer a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on...
05.03.2013
- Cheaper generic drugs in 2012 brought down spending on treatments for common diseases like high cholesterol for the first time in 20 years, according to a report from the largest...
06.12.2012
- Teva Pharmaceutical Industries' new Chief Executive Jeremy Levin has promised investors it will be a very different company going forward. Next week he has to prove it. Levin's...
30.11.2012
- Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, forecast profit and revenue for calendar 2013 that fell short of analysts' estimates. The Israel-based...
09.11.2012
- Canada's Supreme Court struck down the patent on global pharmaceuticals giant Pfizer's Viagra erectile dysfunction drug on Thursday and opened the door to generic competition. The...
01.11.2012
- Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...
01.11.2012
- Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...
02.10.2012
- U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer and a division of Teva Pharmaceuticals to end patent litigation over the...
